Trevi Therapeutics (TRVI) PT Raised to $40 at Raymond James

August 7, 2026 6:25 AM

Raymond James analyst Ryan Deschner raised the price target on Trevi Therapeutics (NASDAQ: TRVI) to $40.00 (from $27.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found